Bender Robert & Associates Buys Alphabet Inc, Advanced Micro Devices Inc, Sells Alphabet Inc, UroGen Pharma, AT&T Inc

Pasadena, CA, based Investment company Bender Robert & Associates (Current Portfolio) buys Alphabet Inc, Advanced Micro Devices Inc, sells Alphabet Inc, UroGen Pharma, AT&T Inc, Clovis Oncology Inc, Evolus Inc during the 3-months ended 2021Q2, according to the most recent filings of the investment company, Bender Robert & Associates. As of 2021Q2, Bender Robert & Associates owns 47 stocks with a total value of $352 million. These are the details of the buys and sells.

For the details of BENDER ROBERT & ASSOCIATES's stock buys and sells, go to https://www.gurufocus.com/guru/bender+robert+%26+associates/current-portfolio/portfolio

These are the top 5 holdings of BENDER ROBERT & ASSOCIATES
  1. Apple Inc (AAPL) - 481,123 shares, 18.72% of the total portfolio. Shares added by 0.08%
  2. Intuitive Surgical Inc (ISRG) - 32,101 shares, 8.39% of the total portfolio. Shares reduced by 0.66%
  3. Amazon.com Inc (AMZN) - 7,958 shares, 7.78% of the total portfolio. Shares added by 1.47%
  4. Illumina Inc (ILMN) - 49,596 shares, 6.67% of the total portfolio. Shares added by 0.56%
  5. MercadoLibre Inc (MELI) - 14,499 shares, 6.42% of the total portfolio. Shares reduced by 0.34%
New Purchase: Advanced Micro Devices Inc (AMD)

Bender Robert & Associates initiated holding in Advanced Micro Devices Inc. The purchase prices were between $73.09 and $93.93, with an estimated average price of $80.78. The stock is now traded at around $85.890000. The impact to a portfolio due to this purchase was 0.28%. The holding were 10,468 shares as of 2021-06-30.

Added: Alphabet Inc (GOOGL)

Bender Robert & Associates added to a holding in Alphabet Inc by 37.96%. The purchase prices were between $2062.52 and $2450.72, with an estimated average price of $2328.99. The stock is now traded at around $2539.400000. The impact to a portfolio due to this purchase was 0.92%. The holding were 4,681 shares as of 2021-06-30.

Sold Out: UroGen Pharma Ltd (URGN)

Bender Robert & Associates sold out a holding in UroGen Pharma Ltd. The sale prices were between $15.2 and $20.94, with an estimated average price of $18.12.

Sold Out: AT&T Inc (T)

Bender Robert & Associates sold out a holding in AT&T Inc. The sale prices were between $28.65 and $32.63, with an estimated average price of $30.11.

Sold Out: Clovis Oncology Inc (CLVS)

Bender Robert & Associates sold out a holding in Clovis Oncology Inc. The sale prices were between $5.02 and $7.05, with an estimated average price of $5.88.

Sold Out: Evolus Inc (EOLS)

Bender Robert & Associates sold out a holding in Evolus Inc. The sale prices were between $8.42 and $13.96, with an estimated average price of $11.05.

Sold Out: IDEXX Laboratories Inc (IDXX)

Bender Robert & Associates sold out a holding in IDEXX Laboratories Inc. The sale prices were between $486.36 and $637.08, with an estimated average price of $550.32.

Sold Out: Pulse Biosciences Inc (PLSE)

Bender Robert & Associates sold out a holding in Pulse Biosciences Inc. The sale prices were between $16.31 and $23.68, with an estimated average price of $19.16.



Here is the complete portfolio of BENDER ROBERT & ASSOCIATES. Also check out:

1. BENDER ROBERT & ASSOCIATES's Undervalued Stocks
2. BENDER ROBERT & ASSOCIATES's Top Growth Companies, and
3. BENDER ROBERT & ASSOCIATES's High Yield stocks
4. Stocks that BENDER ROBERT & ASSOCIATES keeps buying